Search - tctmd.com

Displaying 121 - 140 of 7545

Sort: Relevancy | Date

Presentation TCT 2025

TCT 924: Association of Patient-Reported Outcomes (PROs) in Chronic Limb-Threatening Ischemia (CLTI) Patients with Baseline Clinical Characteristics and Outcomes

Presenter: Jennifer Rymer

October 26, 2025

Presentation TCT 2025

TCT 926: Real-World Trends and Comparative Outcomes of PTA vs PTA + Atherectomy: An EPIC COSMOS Analysis of Index Admissions (2017–2024)

Presenter: Anand Gupta

October 26, 2025

Presentation TCT 2025

TCT 923: Balloon-expandable Stent-grafts Versus Internal Iliac Component for Endovascular Repair of Iliac Artery Aneurysms with Gore Iliac Branch Endoprosthesis

Presenter: Joshua Davis

October 26, 2025

Presentation TCT 2025

TCT 921: Comparison of Skin Perfusion Pressure and Transcutaneous Oxygen Pressure for Predicting Early Wound Healing After Endovascular Therapy in Patients With Chronic Limb-Threatening Ischaemia

Presenter: Bokyung Jeon

October 26, 2025

Presentation TCT 2025

TCT 925: Peripheral Endovascular Intervention with Atherectomy in Below-The-Knee Arteries: A Report from The XLPAD Registry

Presenter: Minseob Jeong

October 26, 2025

Presentation TCT 2025

TCT 922: Duration-Dependent Outcomes of Dual Antiplatelet Therapy Following Peripheral Endovascular Revascularization: A Systematic Review and Meta-Analysis of Target Vessel Patency, Limb Salvage, and Safety Events

Presenter: Zeyad Kholeif

October 26, 2025

Presentation TCT 2025

TCT 1201: National prevalence, temporal trends, and predictors of same day discharge after PCI for NSTE-ACS in clinical practice: A report from the NCDR-CathPCI Registry

Presenter: Sunil V. Rao

October 26, 2025

Presentation TCT 2025

TCT 146: Treatment of calcified de novo coronary artery lesions with drug-coated balloon after intravascular lithotripsy

Presenter: Tuomas T. Rissanen

October 26, 2025

Presentation TCT 2025

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

Presenter: Christina Lalani

October 26, 2025

Presentation TCT 2025

TCT 307: 20-Year Follow-up After Patent Foramen Ovale Closure in Patients With Cryptogenic Embolism

Presenter: Pablo Vidal Calés

October 26, 2025

Presentation TCT 2025

TCT 176: Mid-Term Outcomes of PCI in In-Stent Restenosis versus De-Novo Lesions in an Urban Center with a Large African American Population: An Updated Retrospective Analysis

Presenter: Ankit Hanmandlu

October 26, 2025

News Opinion CV Team Dispatch

October 2025 Dispatch for the CV Team

L.A. McKeown

October 25, 2025

Presentation TCT 2025

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Presenter: Grant William Reed

October 25, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Yael L. Maxwell

October 24, 2025

News Daily News

Alterations in Alcohol Use, Even at Low Levels, Impact BP

Todd Neale

October 24, 2025

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

Todd Neale

October 22, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Caitlin E. Cox

October 21, 2025

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Conference News EACTS 2025

Mortality at 4 Years After TAVI Explant Linked to Hospital Volume: Medicare Data

Yael L. Maxwell

October 16, 2025

Advertisement

TCT 924: Association of Patient-Reported Outcomes (PROs) in Chronic Limb-Threatening Ischemia (CLTI) Patients with Baseline Clinical Characteristics and Outcomes

TCT 926: Real-World Trends and Comparative Outcomes of PTA vs PTA + Atherectomy: An EPIC COSMOS Analysis of Index Admissions (2017–2024)

TCT 923: Balloon-expandable Stent-grafts Versus Internal Iliac Component for Endovascular Repair of Iliac Artery Aneurysms with Gore Iliac Branch Endoprosthesis

TCT 921: Comparison of Skin Perfusion Pressure and Transcutaneous Oxygen Pressure for Predicting Early Wound Healing After Endovascular Therapy in Patients With Chronic Limb-Threatening Ischaemia

TCT 925: Peripheral Endovascular Intervention with Atherectomy in Below-The-Knee Arteries: A Report from The XLPAD Registry

TCT 922: Duration-Dependent Outcomes of Dual Antiplatelet Therapy Following Peripheral Endovascular Revascularization: A Systematic Review and Meta-Analysis of Target Vessel Patency, Limb Salvage, and Safety Events

TCT 1201: National prevalence, temporal trends, and predictors of same day discharge after PCI for NSTE-ACS in clinical practice: A report from the NCDR-CathPCI Registry

TCT 146: Treatment of calcified de novo coronary artery lesions with drug-coated balloon after intravascular lithotripsy

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

TCT 307: 20-Year Follow-up After Patent Foramen Ovale Closure in Patients With Cryptogenic Embolism

TCT 176: Mid-Term Outcomes of PCI in In-Stent Restenosis versus De-Novo Lesions in an Urban Center with a Large African American Population: An Updated Retrospective Analysis

October 2025 Dispatch for the CV Team

Treatment Adherence and Adverse Events After Combined TAVR and LAAC or TAVR and Oral Anticoagulation in Patients with Atrial Fibrillation: The WATCH-TAVR OAC Compliance Study

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Alterations in Alcohol Use, Even at Low Levels, Impact BP

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Mortality at 4 Years After TAVI Explant Linked to Hospital Volume: Medicare Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content